Fillerfy® MESO DNA+ (5x10ml)
Original price was: $200.00.$100.00Current price is: $100.00.
- Description
- Shipping & Delivery
- Reviews (0)
Description
🧬 Salmon DNA: Boosts cell regeneration, enhances moisture levels, and restores skin vitality with a healthy glow.
🧬 X-DNA (PDRN): Stimulates fibroblast activity for collagen synthesis, improves elasticity, and promotes long-term rejuvenation and tightening.
This advanced Fillerfy DNA+ biorevitalizing formula delivers both instant radiance and deep tissue repair, rebuilding the skin from within.
Key Benefits:
- Intense hydration and radiant glow
- Deep skin regeneration and repair
- Visible anti-aging and lifting effects
- Smooths fine lines and evens skin tone
- Fast recovery after application or procedures
- Facial, neck, décolleté, and hand mesotherapy
- Post-laser, peeling, or filler skin recovery
- Dull, tired, or sagging skin lacking elasticity
Treatment Protocol
Mesotherapy
- Dosage: 2.5–3 ml per session
- Sessions: 4–6
- Frequency: Every 15–21 days
Dermapen
- Dosage: 3 ml per session
- Sessions: 4–6
- Frequency: Every 15–21 days
Fast, Reliable Worldwide Shipping
At Fillerfy®, we provide secure and efficient international shipping for professional aesthetic and medical products.
-
Worldwide Delivery: International shipping to supported destinations.
-
Fast Order Processing: Orders are prepared promptly after payment confirmation.
-
Secure Packaging: Products are carefully packaged to protect their quality during transit.
-
Temperature-Controlled Shipping: Available for eligible temperature-sensitive products.
-
Order Tracking: Tracking information is provided when available.
-
Dedicated Support: Our team is available via WhatsApp for shipping inquiries and delivery assistance.
Delivery Times: Shipping times vary depending on the destination, product availability, customs clearance, and selected shipping method.
Need Shipping Assistance?
Contact our team via WhatsApp for delivery estimates, shipping options, and order assistance.
Reviews
There are no reviews yet.